Category: Nasdaq:EIKN

MILLBRAE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) — Eikon Therapeutics, Inc. (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing important, innovative medicines to address…